Stay updated on Emricasan in NASH Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Emricasan in NASH Fibrosis Clinical Trial page.

Latest updates to the Emricasan in NASH Fibrosis Clinical Trial page
- Check7 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedRevision label updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.0%

- Check50 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3. This update does not alter study details or page functionality.SummaryDifference0.0%

- Check71 days agoChange DetectedFooter update: Revision v3.4.2 added and Revision v3.4.1 removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check79 days agoChange DetectedThe page shows a minor system revision update (Revision: v3.4.1) with no changes to study content, eligibility criteria, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check93 days agoChange DetectedUI/text changes include showing/hiding glossary, capitalization tweaks to QC-related labels, and a new Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Emricasan in NASH Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Emricasan in NASH Fibrosis Clinical Trial page.